Pre-Fasting Assessment Questions for Patients Planning to Fast
When evaluating a patient planning to fast, you must conduct a structured risk stratification interview covering demographics, medical conditions, medications, monitoring capacity, and safety planning to prevent life-threatening complications including severe hypoglycemia, diabetic ketoacidosis, dehydration, and acute decompensation of chronic diseases.
Essential Demographic and Baseline Information
Start by documenting:
- Age and sex (women and children may have lower glucose levels during prolonged fasting without pathology) 1
- Previous fasting experience – Has the patient fasted before? What complications occurred? 2
- Duration and type of planned fast – Hours per day, total days, complete vs. partial restriction
Critical Medical History Assessment
High-Risk Conditions Requiring Detailed Evaluation
Diabetes mellitus (highest priority):
- Type 1 vs. Type 2 diabetes
- Current glycemic control (recent HbA1c, typical glucose ranges)
- History of severe hypoglycemia or diabetic ketoacidosis
- Presence of diabetic complications (neuropathy, retinopathy, nephropathy)
- "Brittle" or poorly controlled diabetes is a contraindication to fasting 3
Chronic kidney disease:
- Current stage and renal function (creatinine, eGFR)
- Risk of dehydration-induced acute kidney injury 2
Cardiovascular disease:
- Heart failure status and functional class
- Recent cardiac events or unstable angina
- Hypertension control
Endocrine disorders:
- Adrenal insufficiency (absolute contraindication without stress-dose adjustment)
- Thyroid disease control
Psychiatric conditions and eating disorders:
- Active eating disorders (contraindication to fasting)
- Psychiatric stability and medication adherence
- Cognitive ability to recognize warning signs
Pregnancy and lactation (contraindication to prolonged fasting)
Liver disease severity and synthetic function
Comprehensive Medication Review
Medications Requiring Dose Adjustment or Discontinuation
Insulin regimens 3:
- Current doses and timing
- For twice-daily premixed insulin: Plan to use usual morning dose at sunset meal and half the evening dose at predawn
- Type 1 diabetes patients must never completely stop insulin 3
Oral hypoglycemics 3:
- Sulfonylureas (high hypoglycemia risk): Shift full dose to sunset meal, use half dose at predawn
- Metformin: Redistribute to 1000mg at sunset, 500mg at predawn
- SGLT2 inhibitors: Increased risk of dehydration and euglycemic ketoacidosis during fasting 4, 5, 6
- DPP-4 inhibitors: Generally safer, minimal adjustment needed
- GLP-1 receptor agonists: Lower hypoglycemia risk but assess hydration status 7
Glucocorticoids:
- Dose, timing, and indication
- Risk of hyperglycemia and immunosuppression
Diuretics:
- Type and dose
- Dehydration and electrolyte imbalance risk
ACE inhibitors/ARBs:
- Risk of acute kidney injury with dehydration
- Hyperkalemia risk
Anticoagulants:
- INR stability
- Dietary vitamin K changes affecting warfarin
Antiepileptics:
- Seizure control and medication levels
- Can be taken with sips of water 8
Antipsychotics and mood stabilizers:
- Metabolic effects and adherence during fasting
Thyroid hormone:
- Can be taken with water on empty stomach 8
Immunosuppressants:
- Timing relative to meals and infection risk
Monitoring and Safety Planning
Glucose Monitoring Capacity (Critical for Diabetes)
- Availability of glucometer and supplies 3
- Frequency of planned monitoring: Multiple times daily for insulin users 3
- Patient's ability to interpret results and act appropriately
Planned Fluid Intake Strategy
- Type and volume of permitted fluids (calorie-free beverages allowed during diagnostic fasts) 1
- Timing of hydration (adequate intake during non-fasting hours) 3
- Recognition of dehydration signs
Absolute Criteria for Breaking the Fast
Patients must understand they must immediately terminate fasting if 3:
- Glucose <60 mg/dL (3.3 mmol/L) at any time
- Glucose <70 mg/dL (3.9 mmol/L) in first few hours after starting fast (especially on insulin, sulfonylureas, or meglitinides)
- Glucose >300 mg/dL (16.7 mmol/L)
- Symptomatic hypoglycemia regardless of glucose reading
- Acute illness ("sick days")
- Severe dehydration symptoms
- Chest pain, severe weakness, confusion, or other acute symptoms
Support System Assessment
- Caregiver availability to recognize complications
- 24-hour contact number for medical provider 8
- Access to emergency glucose (glucose gel, tablets, glucagon) 3
- Medical alert identification 3
Re-feeding Plan
- Meal composition and timing after fast ends
- Avoidance of overeating at sunset meal (risk of postprandial hyperglycemia) 3
- Distribution of calories over 2-3 smaller meals during non-fasting interval 3
Medical Clearance Documentation
- Has the patient received formal medical assessment 1-2 months before planned fasting? 3, 2
- Recent laboratory work: HbA1c, renal function, electrolytes, liver function 2
- Risk stratification completed (very high, high, moderate, or low risk) 2
- Trial fasting attempted with adjusted medication regimen 2
- Written action plan provided with specific glucose targets and break-fast criteria
Common Pitfalls to Avoid
- Never rely on point-of-care glucose monitors alone for critical decisions during diagnostic fasting; use laboratory-measured plasma glucose 1
- Do not assume all patients understand hypoglycemia symptoms – explicitly review confusion, sweating, tremor, palpitations
- Avoid generic advice – medication adjustments must be patient-specific based on regimen and risk factors 3
- Do not permit fasting in type 1 diabetes patients who are brittle, poorly controlled, or unwilling to monitor glucose multiple times daily 3
- Recognize that healthy women and children may have glucose <60 mg/dL during prolonged fasting without pathology 1
This structured assessment prioritizes prevention of acute complications that directly impact morbidity and mortality, particularly severe hypoglycemia in diabetes patients and dehydration-related organ dysfunction.